Based on the available information, the decision to get vaccinated while on Cosentyx (secukinumab) therapy should be made in consultation with a healthcare provider. Cosentyx is a medication used to treat a variety of conditions, including psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It is a type of drug known as a biologic, which works by targeting specific proteins in the immune system [1].

According to the Centers for Disease Control and Prevention (CDC), individuals on biologic therapy for immune-mediated inflammatory diseases, such as those treated with Cosentyx, can and should receive vaccines [2]. However, it is important to note that the immune response to vaccination may be reduced in individuals on biologic therapy [2].

The manufacturer of Cosentyx, Novartis, states that the safety and efficacy of vaccination during Cosentyx therapy have not been studied [3]. They recommend that patients be brought up-to-date with all vaccinations, including live-virus vaccines, prior to initiating Cosentyx therapy, if possible [3].

In summary, while it is possible to receive vaccinations while on Cosentyx therapy, it is important to discuss the potential risks and benefits with a healthcare provider. It is also recommended to receive any necessary vaccinations prior to starting Cosentyx therapy, if possible.

Sources:

1. Cosentyx (secukinumab) [Prescribing Information]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2021. Available from: <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>.
2. General Best Practice Guidelines for Immunization: Best Practices Guidance of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. Available from: <https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html>.
3. Novartis. (2021). Cosentyx (secukinumab) frequently asked questions. DrugPatentWatch.com. Retrieved from <https://www.drugpatentwatch.com/faq/cosentyx-secukinumab-1553.html>.